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EL SNP INTRÓNICO rs3811647 DEL GEN DE LA
TRANSFERRINA HUMANO, MODULA SU 
EXPRESIÓN EN CÉLULAS HEPÁTICAS
Resumen
Introducción: La transferrina (Tf) ejerce una función
crucial en el mantenimiento de la homeostasis sistémica
del hierro. La expresión del gen de la transferrina es con-
trolada a nivel transcripcional, aunque la posible influen-
cia de factores genéticos todavía es desconocida.
Objetivo: Estudiar el papel del rs3811647 en la expre-
sión de la transferrina mediante un ensayo in-vitro en
células de hepatoma.
Diseño y métodos: Células Hep3B fueron co-transfecta-
das con vectores que contenían las variantes A (VarA-Tf-
luc) y G (VarG-Tf-luc) del rs3811647, utilizandose la luci-
ferasa como marcador de la expresión del gen Tf. 
Resultados: Los ensayos con la luciferasa mostraron un
mayor aumento de la expresión del gen Tf en presencia de
la variante A comparada con la G (p < 0,05). El análisis in
silico del SNP rs3811647 mostró que la presencia del alelo
A puede constituir un sitio de unión del receptor de gluco-
corticoides (GR).
Conclusión: El alelo A del SNP rs3811647 incrementa
la expresión del gen Tf de modo que podría modular la
variación interindividual en los niveles de transferrina
sérica observados en diferentes poblaciones.
(Nutr Hosp. 2012;27:2144-2147)
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Abstract
Introduction: Transferrin (Tf) exerts a crucial function
in the maintenance of systemic iron homeostasis. The
expression of the Tf gene is controlled by transcriptional
mechanism, although little is known about genetic factors
influence.
Objective: To study the role of rs3811647 in Tf expres-
sion using an in-vitro assay on hepatoma cells.
Design and Methods: Hep3B cells were co-transfected
with constructs containing A (VarA-Tf-luc) and G
(VarG-Tf-luc) variants of rs3811647, using luciferase as a
surrogate reporter of Tf expression. 
Results: Luciferase assays showed a higher intrinsic
enhancer activity (p < 0.05) in the A compared with the G
variant. In silico analysis of SNP rs3811647 showed that
the A allele might constitute a binding site for the tran-
scription factor glucocorticoid receptor (GR).
Conclusion: The A allele of SNP rs3811647 increases
Tf expression in a manner that might underlie inter-indi-
vidual variation in serum transferrin levels observed in
different population groups.
(Nutr Hosp. 2012;27:2144-2147)
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Introduction
Transferrin (Tf) is an iron-binding plasma protein that
delivers iron to cells via the transferrin receptor pathway.1
A molecule of Tf can bind two atoms of ferric iron with
high affinity. Iron chelation by transferrin serves three
main purposes: to maintain ferric iron in a soluble form
under physiologic conditions; to facilitate regulated iron
transport and cellular uptake, and to maintain ferric iron
in a redox-inert state, avoiding the generation of free radi-
cals.2 Moreover, diferric Tf stimulates hepcidin expres-
sion, the central regulatory molecule of systemic iron
homeostasis, through a TfR2/HFE mediated pathway.3
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The expression of the Tf gene is controlled by tran-
scriptional mechanisms and is tissue-specific.4 Many
environmental factors are known to affect plasma Tf
levels: in iron deficiency, the rate of Tf synthesis in the
liver increases significantly,5 whereas inflammatory or
immunologic stimuli may decrease the levels of circu-
lating Tf.6 Recent studies observed increased Tf levels
under hypoxia, a response that may facilitate iron
supply for erythropoiesis.7 Nevertheless, little is known
about the genetic factors that influence Tf levels in
humans, although its expression pattern appears to
show sexual dimorphism.8 Our research group recently
published that only a few SNPs could explain a large
percentage of the heritable variation of serum trans-
ferrin levels; one of these loci is SNP rs3811647,
located in intron 11 of the human transferrin gene (Tf),9
which as in agreement with other data from the bibliog-
raphy.10 Based on these studies, we hypothesised that
SNP rs3811647 increases transferrin expression. Here
we show that this SNP constitutes an intronic enhancer
that modulates Tf expression in hepatoma cells.
Design and methods
Plasmid constructs
A fragment of approximately 500 bp of intron 11 of
the human transferrin gene (Tf), encompassing the SNP
rs3811647, was amplified from placental genomic DNA
with the following primers: sense, CATGCTAGCG-
GCTTGCACACAGGATTTTT; antisense, CATCTC-
GAGAATCAGTGGAAGTGGCAAGG; NheI and
XhoI restriction sites are underlined. The cycling para-
meters were: 95° C for 5 minutes, then 95° C for 5
minutes (denaturation), 62° C for 1 minute (annealing),
and 72° C for 1 minute (extension); 35 cycles of PCR
were performed with a final extension for 10 minutes at
72° C. The PCR product was subcloned into pGEM-T
Easy vector (Promega, Southampton, United Kingdom)
and sequenced for verification of the nucleotide
sequence (MWG Biotech, Ebersberg, Germany) and to
confirm the presence of the A allele. The construct was
digested with NheI and XhoI (New England Biolabs,
Hitchin, United Kingdom), and the insert was purified
with Geneclean (BIO101; Anachem, Luton, United
Kingdom) and ligated into the NheI and XhoI sites of
pGL3Promoter (Promega) to generate VarA-Tf-luc.
Site-directed mutagenesis
VarA-Tf-luc was subjected to site-directed mutagen-
esis using the QuikChange Multi Site-Directed Mutage-
nesis system (Stratagene, Amsterdam, The Netherlands)
as instructed by the manufacturer. To change the A to G
alleles we synthesized a mutagenic primer (mutations
in lowercase) as follows: GGGAGTTTACAGACA-
GATCgTCTAGGATTATACATCTAGGAAGGG.
After initial denaturation for 5 minutes at 95° C, PCR
cycling parameters were 95° C (5 minutes), 55° C (1
minute), and 65° C (11 minutes and 12 seconds), for a
total of 30 cycles. Plasmids were sequenced to verify
that the intended mutation had occurred. The resulting
construct was designated VarG-Tf-luc.
Cell culture, transfection and luciferase assay
The human hepatoma cell line Hep3B was obtained
from Antonello Pietrangelo and cultured in Dulbecco’s
Modified Eagle Medium (DMEM), supplemented with
10% foetal calf serum (FCS) and antibiotics/antimy-
cotics (Invitrogen). Cells were grown under standard
cell culture conditions of 37° C and 5% CO2; for trans-
fection, cells were seeded in 24-well plates at densities
of approximately 104 cells/well. Cells were transfected
with 100 ng/well of VarA-Tf-luc or VarG-Tf-luc with
Lipofectamine 2000 (Invitrogen), as instructed by the
manufacturer. As internal control, 50 ng of pSV gal
vector (Promega) was included in all transfections to
normalize transfection efficiencies. Cells were
harvested after 48 hours for reporter assays; luciferase
activities were determined with the luciferase assay
reagent and β-galactosidase (βgal) activity was
measured using the Beta-Glo reagent (both from
Promega). Luminescence was measured in a Tropix
TR717 microplate luminometer (Applied Biosystems);
luciferase levels were normalized with respect to gal
activity in the samples.
In silico analysis
For the prediction of putative transcription factor
binding sites, a sequence of 25 bases to either side of
the SNP rs3811647 was submitted to a net-based
search tool Patch 1.0 (http://www.gene-regulation.
com/cgi-bin/pub/programs/patch/bin/patch.cgi).
Settings for core and pair similarities, matrix conser-
vation, and factor class levels were adjusted according
to factors predicted.
Statistical analysis
Pairwise comparisons of control and SNP constructs
were made using ANOVA test. A P value of 0.05 was
considered significant. Graphs were plotted with the
GraphPad Prism software and data were analysed
using the SPSS statistical package for Windows
(version 19.0; SPSS Inc., Chicago, IL, USA).
Results
Using reporter assays in which fragments of the
intron encompassing SNP rs3811647 were ligated to
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firefly luciferase as Tf surrogate, we found that the A
allele enhanced gene expression compared with the G
allele. The fold activation of the VarA-Tf-luc construct
was significantly higher (p < 0.05) than that of the
VarG-Tf-luc construct (fig. 1). In other words, the A
allele of the SNP rs3811647 supports higher Tf expres-
sion than the G allele in hepatoma cells.
In silico analysis of this SNP showed that the A
allele in rs3811647 could theoretically constitute a
binding site for the glucocorticoid receptor (GR), also
known as nuclear receptor subfamily 3 group C
member 1 (NR3C1), whereas this binding site is lost
with the G allele (fig. 2).
Discussion
The obtained results can be validated by the findings
that our research group obtained in a group of menstru-
ating women. We found that serum transferrin was
significantly higher in AA homozygous women than in
AG heterozygous and GG homozygous (p < 0.01), and
serum transferrin saturation was significantly higher in
GG than in AG and AA women (p = 0.01).9 Also, the
in-vitro results confirm previous observations in
different population groups10-13 and add new informa-
tion concerning the functionality of rs3811647. We
therefore suggest that basal differences in circulating
Tf levels between individuals may be ascribed to SNP
rs3811647, which is located in intron 11 of Tf gene
(Chr3q22.1). 
The tissue-specificity of Tf expression is accom-
plished by the recruitment of different combinations of
transcription factors. In hepatocytes, binding sites of
transcription factors that are well-known to regulate Tf
expression have been described. Proximal region I
(PRI) and proximal region II (PRII) within the Tf
promoter positively regulate its expression in the liver
whereas distal regions repress Tf expression.14
However, our study shows that in addition to the posi-
tive regulation of Tf by proximal promoter elements,
there are intronic elements such as rs3811647 that
could act as enhancers of Tf transcription. This is
intriguing because no known function especially in
relation to relative risk would have been predicted for
intronic sequences,15 considering that disease associa-
tions have hitherto been limited to coding-region muta-
tions only. We found that presence of the A allele of
rs3811647 might constitute a binding site for the GR.
Glucocorticoids influence the expression of a number
of genes involved in iron metabolism including ferritin,
ferroportin, DMT-1 and iron regulatory protein-1.16,17
GR might therefore regulate glucocorticoid-dependent
differences in Tf allele expression; further studies will
ascertain this. Although it is more frequent to find
regulatory regions upstream of the start site of tran-
scription, in some cases transcription factors are able to
drive gene expression from within coding regions.18 It
is therefore not entirely surprising that we found regu-
latory regions within the Tf intron.
In our previous study, the women that presented the
A allele also had lower transferrin saturation, which
may indicate a reduction in iron transport to tissues.9
Since low ferritin levels have been associated with this
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Fig. 1.—SNP rs3811647 luciferase assay. Hep3B cells were
transfected with VarA-Tf-luc or VarG-Tf-luc constructs; pGL3
(Promoter) vector backbone was used as negative control. Data
were normalized to the expression levels of β-galactosidase in-
ternal control, and represent the means of two independent ex-
periments (± SEM), *p < 0.05.
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Fig. 2.—Genomic arrangement (upper panel) and sequences proximal to SNP rs3811647 (bold letter, lower panel). Sequence analysis
with prediction algorithms showed that the A allele in rs3811647 might create a binding site for the glucocorticoid receptor (GR).
rs3811647
Allele A: AAGCTGAGGGAGTTTACAGACAGATCATCTAGGATTATACATCTAGGAAGGG
Allele G: AAGCTGAGGGAGTTTACAGACAGATCGTCTAGGATTATACATCTAGGAAGGG
==GR==
0M 10M 20M 30M 40M 50M 60M 70M 80M 90M 100M 110M 120M 130M 140M 150M 160M 170M 180M 190M
48. INTRONIC:01. Interacción  13/11/12  13:36  Página 2146
SNP, it could be related to low iron status.10 Another
important observation was made in a placebo-
controlled nutritional intervention study with iron-
fortified food in iron-deficient women.19 Dietary iron-
fortification markedly increased the iron status in all
women. However, carriers of the minor A allele
showed Tf levels higher than the rest during the 16-
week intervention period.20 All of these observations
suggest that this SNP may affect iron metabolism.
In conclusion, we found that the A allele of the SNP
rs3811647 enhances Tf expression compared with the
G allele, and that this might explain the association
between this SNP and the high serum Tf levels
observed in different population groups.
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